Roche Holding AG logo

ROG - Roche Holding AG Share Price

CHF315.3 6.5  2.1%

Last Trade - 10:55am

Sector
Healthcare
Size
Large Cap
Market Cap £218.93bn
Enterprise Value £224.69bn
Revenue £51.66bn
Position in Universe 4th / 1044
Bullish
Bearish
Unlock ROG Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ROG Revenue Unlock ROG Revenue

Net Income

ROG Net Income Unlock ROG Revenue

Normalised EPS

ROG Normalised EPS Unlock ROG Revenue

PE Ratio Range

ROG PE Ratio Range Unlock ROG Revenue

Dividend Yield Range

ROG Dividend Yield Range Unlock ROG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ROG EPS Forecasts Unlock ROG Revenue
Profile Summary

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated April 13, 1966
Public Since May 4, 2001
No. of Shareholders: n/a
No. of Employees: 97,735
Sector Healthcare
Industry Pharmaceuticals
Index FTSEurofirst 300 Pharmaceuticals & Biotechnology , FTSEurofirst 300 , FTSEurofirst 300 Ex Eurozone, FTSEurofirst 300 Ex UK, FTSE Global 100,
Exchange SIX Swiss Exchange (VTX)
Shares in Issue 855,756,455
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ROG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ROG
Upcoming Events for ROG
Wednesday 22nd April, 2020
Q1 2020 Roche Holding AG Corporate Sales Release
Wednesday 22nd April, 2020
Q1 2020 Roche Holding AG Corporate Sales Call
Monday 4th May, 2020
Roche Holding AG to Discuss Data Presented at AAN 2020 Call
Thursday 7th May, 2020
Roche Holding AG Virtual Digital Technology and Advanced Analytics Event
Thursday 14th May, 2020
Roche Holding AG at Berenberg Diagnostics Conference
Tuesday 19th May, 2020
Roche Holding AG at UBS Global Life Sciences Conference
Saturday 30th May, 2020
Roche Holding AG Analyst Event at ASCO 2020
Tuesday 2nd June, 2020
Roche Holding AG at Jefferies Healthcare Conference
Wednesday 3rd June, 2020
Roche Holding AG at Deutsche Bank dbAccess Berlin Conference
Tuesday 9th June, 2020
Roche Holding AG at Goldman Sachs Global Healthcare Conference
Tuesday 9th June, 2020
Roche Holding AG at Mainfirst Swiss Equity Conference
Thursday 11th June, 2020
Roche Holding AG at Exane Bnp Paribas European CEO Conference
Thursday 18th June, 2020
Roche Holding AG at JPMorgan European Healthcare Conference
Friday 19th June, 2020
Roche Holding AG at Barclays European Select Conference
Tuesday 23rd June, 2020
Roche Holding AG at Bank of America Merrill Lynch Napa Healthcare Conference
Thursday 23rd July, 2020
Half Year 2020 Roche Holding AG Earnings Release
Thursday 23rd July, 2020
Half Year 2020 Roche Holding AG Earnings Call
Tuesday 28th July, 2020
Roche Holding AG AACC - Analyst Event
Wednesday 12th August, 2020
Roche Holding AG at UBS Genomics 2.0 and Medtech Innovations Summit
Wednesday 9th September, 2020
Roche Holding AG at Citi BioPharma Conference
Similar to ROG
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.